The news: Full body medical scanning startup Neko Health bagged $260 million in Series B funding that values the company at $1.8 billion, according to Axios. The round was led by Lightspeed Venture Partners, with General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico also participating.
How it works: Neko scans take 15 minutes and use a mix of thermal scanners, EKGs, and sensors to detect conditions such as skin cancer, heart disease, or Type 2 diabetes. Scans are followed up by doctor’s visits at Neko’s clinics to track patients’ health changes over time.
Why it matters: Full body medical scanning startups have been the subject of debate, particularly due to the cost of their services.
If Neko can make full body medical scanning more affordable (it’s currently not covered by insurance), it could open up access to its services to a wide swath of consumers eager for a holistic view of their overall health.
Our take: Neko feels overvalued at $1.8 billion, especially considering consumers' affordability challenges when it comes to paying for health services.
While celebrities have used and endorsed the services of full body scan startups on social media, they typically have deep enough pockets to afford them—unlike the average consumer.
This article is part of EMARKETER’s client-only subscription Briefings—daily newsletters authored by industry analysts who are experts in marketing, advertising, media, and tech trends. To help you start 2025 off on the right foot, articles like this one—delivering the latest news and insights—are completely free through January 31, 2025. If you want to learn how to get insights like these delivered to your inbox every day, and get access to our data-driven forecasts, reports, and industry benchmarks, schedule a demo with our sales team.